PMID- 29066029
OWN - NLM
STAT- In-Data-Review
LR  - 20180616
IS  - 1873-7560 (Electronic)
IS  - 0302-2838 (Linking)
VI  - 74
IP  - 1
DP  - 2018 Jul
TI  - Antitumor Activity and Safety of Enzalutamide After Abiraterone Acetate: Seeking 
      the Optimal Treatment Sequence for Castration-resistant Prostate Cancer Patients.
PG  - 46-47
LID - S0302-2838(17)30858-8 [pii]
LID - 10.1016/j.eururo.2017.09.038 [doi]
FAU - Saito, Kazutaka
AU  - Saito K
AD  - Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.
      Electronic address: kz-saito.uro@tmd.ac.jp.
FAU - Fujii, Yasuhisa
AU  - Fujii Y
AD  - Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.
LA  - eng
PT  - Editorial
DEP - 20171021
PL  - Switzerland
TA  - Eur Urol
JT  - European urology
JID - 7512719
EDAT- 2017/10/27 06:00
MHDA- 2017/10/27 06:00
CRDT- 2017/10/26 06:00
PHST- 2017/09/11 00:00 [received]
PHST- 2017/09/14 00:00 [accepted]
PHST- 2017/10/27 06:00 [pubmed]
PHST- 2017/10/27 06:00 [medline]
PHST- 2017/10/26 06:00 [entrez]
AID - S0302-2838(17)30858-8 [pii]
AID - 10.1016/j.eururo.2017.09.038 [doi]
PST - ppublish
SO  - Eur Urol. 2018 Jul;74(1):46-47. doi: 10.1016/j.eururo.2017.09.038. Epub 2017 Oct 
      21.